Company Overview

Development Stage

About the Company

杭州湃肽生化科技有限公司致力于药物多肽的研发,申报以及客户定制肽的研究。公司是专业从事GMP药物肽生产,研发、注册报批、咨询以及客户肽研发的科技型高新技术企业,也是目前国内新兴的的专业多肽药品研发机构之一。杭州湃肽生化科技有限公司隶属于浙江湃肽生物股份有限公司。公司拥有目前有员工近150名,20%为硕士以上学历,100%为大专以上学历,主要科研人员均拥有药品开发和注册领域十年以上的工作经验,完成过各种多肽药品研究和注册申请。公司下属生产部、质量部、销售部和工程设备部等部门,能够完成合成工艺开发、药品质量研究、注册申报等药品研发业务;公司拥有近3000平米的药品研发标准实验室,配备了齐全的药品研发仪器设备;按照新版GMP要求新建的10000多平米现代化药物生产基地在绍兴投入使用。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (11 open positions)

Manage
Note: How fast is hiring at 杭州湃肽生化科技有限公司 growing? 2026: 17 openings (down 50%), 2025: 34 openings (up 240%), 2024: 10 openings (down 29%), 2023: 14 openings (up 75%), 2022: 8 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2024 — 6 fewer jobs than 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 杭州湃肽生化科技有限公司 growing? Master's recruitment over the years: 2024: 1 openings (down 29%), 2023: 7 openings (up 75%).

— What Are the Salaries Like? (17 records)

Manage
salary range: 6K - 20K, 76.5% of roles pay ¥8-15K
Note: salary statistics are based on 17 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 杭州湃肽生化科技有限公司?76.5% of positions earn 8-15K, Undergraduate salary: ¥。其他(研发和技术类) average salary ¥10.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 其他(研发和技术类)
    52.9% of total 52.9%
  • 生物/制药/化工/环保类
    47.1% of total 47.1%
  • 科研类
    47.1% of total 47.1%
  • 其他类
    11.8% of total 11.8%

Education

  • 本科
    88.2% of total 88.2%
  • 高中
    5.9% of total 5.9%
  • 大专
    5.9% of total 5.9%

Experience

  • 3-5年
    35.3% of total 35.3%
  • 1-3年
    29.4% of total 29.4%
  • 不限
    23.5% of total 23.5%
  • 5-10年
    11.8% of total 11.8%
View Detailed Analysis

What does 杭州湃肽生化科技有限公司 require? Who is 杭州湃肽生化科技有限公司 hiring? recruitment: 其他(研发和技术类)占比最多占52.9%,其次是生物/制药/化工/环保类占47.1%. What education can get in at ? 本科占比最多占88.2%,其次是高中占5.9%. Work experience required at ? 3-5年占比最多占35.3%,其次是1-3年占29.4%. Where are the job locations at ? 杭州占比最多占88.2%,其次是绍兴占11.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 100万(元)
Legal Representative: 刘志国
Date Established:
Credit Code: 913301100992754170
Registered Address: 浙江省杭州经济技术开发区下沙街道福城路291号4-502室

People who follow this company also follow

Competitors (Similar Companies)

“主要从事多肽产品的研发、生产、销售及相关服务”
生物科技/生物工程 试剂 生物试剂 体外诊断试剂
新材料 聚氨酯 化学品 过氧化物
衡器 精密仪器 化学仪器 电子天平
新药研发 CRO 动物实验 气质联用
美容设备 激光 医疗器械 外科医疗器械
“Providing first-class solutions for global new energy applications”
医药 原料药 制药/药业 生产
“Helping partners successfully develop new drugs, reducing R&D costs an”
氧化铝 氢氧化铝 非金属材料 新材料
“Focused on crystal form drug R&D and industrialization”
“Biological diagnostic reagents and pharmaceuticals”
激光 工业自动化 自动化设备 光纤激光器
纳米晶 透射电子显微镜 电子显微镜 生物科技/生物工程
医药 研发 新药研发 药物研发

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates